- Sections
- C - Chimiemétallurgie
- C07C - Composés acycliques ou carbocycliques
- C07C 59/50 - Acide mandélique
Détention brevets de la classe C07C 59/50
Brevets de cette classe: 45
Historique des publications depuis 10 ans
|
4
|
4
|
2
|
3
|
0
|
1
|
2
|
5
|
2
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Gilead Sciences, Inc. | 2220 |
5 |
| BASF SE | 21303 |
2 |
| Sandoz AG | 1412 |
2 |
| Actavis Group PTC ehf | 395 |
2 |
| Teva Pharmaceuticals USA, Inc. | 639 |
2 |
| Zhejiang Jiuzhou Pharma Science & Technology Co., Ltd. | 9 |
2 |
| Crinetics Pharmaceuticals, Inc. | 127 |
2 |
| Boehringer Ingelheim International GmbH | 4493 |
1 |
| Kaneka Corporation | 4693 |
1 |
| Abbvie Inc. | 1836 |
1 |
| The Board of Trustees of the University of Illinois | 2750 |
1 |
| Takeda Pharmaceutical Company Limited | 2715 |
1 |
| Arch Pharmalabs Limited | 16 |
1 |
| Cadila Healthcare Limited | 294 |
1 |
| Celgene Corporation | 1411 |
1 |
| China State Institute of Pharmaceutical Industry | 21 |
1 |
| Cipla Limited | 476 |
1 |
| The First Affiliated Hospital, Third Military University, PLA | 1 |
1 |
| Krka, D.d., Novo Mesto | 99 |
1 |
| Laboratoriya Bio Zet, LLC | 4 |
1 |
| Autres propriétaires | 15 |